Company News

Share this article:
Boehringer Ingelheim will buy much of Wyeth's Fort Dodge Animal Health business when Pfizer's acquisition of Wyeth closes. In the US and Canada, Boehringer Ingelheim would own and market Wyeth's pet and cattle vaccine lines as well as a range of drugs for pets, cattle and other species, including several swine vaccines in Canada.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters